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Conclusion: BB, ACEI/ARB, spironolactone/eplerenone are less often pre-
scribed in elderly patients contrasting with digoxin and anticoagulants pre-
scription. These differences persist after adjustment on LVEF.
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Background: The prevalence of anaemia in chronic heart failure (CHF)
ranges widely from 4 to 70% due to a lack of an established consistent defi-
nition of anaemia in CHF. Furthermore haemodilution impacts haemoglo-
bin concentrations and could be an important cause of anaemia in CHF.
Aims: The IMPACT-RECO program III analysed the impact of NYHA
class of CHF and of comorbidities on therapeutic management of French
outpatients with stable CHF and left ventricular systolic dysfunction.
Methods: This survey was carried out from March 2007 to December 2007
among randomly selected French private cardiologists. 1574 patients with
CHF and left ventricular ejection fraction (LVEF) < 40% were included.
Results: Mean age was 71 ± 11 years, 75% of the patients were men,
34% were in NYHA class III-IV, 54% had coronary artery diseases, 30%
had atrial fibrillation and the mean LVEF was 34 ± 7%. Haemoglobin
concentration was recorded in 953 patients. Anemia was defined as a hae-
moglobin concentration < 12 g/L in women and < 13 g/L in men. The
impact of NYHA class and congestive status in haemoglobin concentra-
tions are summarized in the table.
Conclusions: Congestive status impacts haemoglobin concentrations more
than the severity of CHF estimated by NYHA class. Haemodilution is an
important aetiology of anaemia in CHF, thus haemoglobin concentration
should be evaluated if possible in patients without congestive signs.
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Background: Right ventricular (RV) function has been proven to be a
major determinant of clinical outcome in Chronic Heart Failure (CHF). The
right and left (L) ventricles inter dependence has been weakly evaluated but
might impact on response to treatments and prognosis.
Aim: We sought to assess the impact of RV-function on LV-function by
studying longitudinal and radial strains in CHF-patients selected for cardiac
resynchronization therapy (CRT).
Methods: Thirty-eight consecutive CHF-patients (New York Heart
Association class III/IV, left ventricular ejection fraction [LVEF] less than
35%, QRS greater than 120 ms) were studied before and after 6-month of
CRT. RV function was assessed by tricuspid annulus plane systolic
velocity (Vs) with a cut-off of 11.5 cm/s. Global LV longitudinal strain
(GLS) was measured (from the apical 4-chamber, apical 3-chamber and
apical 2-chamber views) before and after CRT. Mean radial strain was
measured from the parasternal mid-ventricular view. Reverse remodeling
was defined by echocardiography at 6-month by a decrease in LV end-sys-
tolic volume ≥ 15%.
Results: Eighteen patients had RV-dysfunction (mean Vs=7.6 ±1.2cm/
s) and 20 had normal RV-function (13.6±2.7cm/s). LVEF and volumes
were non different between groups. Patients with RV-dysfunction had sig-
nificantly worst global longitudinal strain before CRT (A-4Ch=-5.3±1.5%
vs. -7.4±2.2%, p=0.01; A-2Ch=-5.7±1.2% vs. -9±2%, p<0.01; A-3Ch=-
5±0.9% vs. -8.4±2.2%, p<0.01). After CRT, differences in global longitu-
dinal strain were still significant. Considering mean radial strain, there
were no differences between groups. The likelihood of response to CRT
was significantly worse in patients having a RV dysfunction (75% vs.
44%, p<0.05).
Conclusion: RV dysfunction diagnosed in patients planed for CRT is asso-
ciated with a significantly worse LV global longitudinal function and a signif-
icantly weak likelihood of response to CRT at 6-month.
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Background: In 2009, in France, heart failure (HF) affects around 1 000
000 Pts and is the first cause of hospitalization among patients (Pts) above
80 years of age. Despite constant progresses, results of HF secondary man-
agement are still moderate. Mortality rates decrease slowly, remaining
around 30 to 40% at 1year and reaching 70% at 5 years. Primary prevention
of HF could therefore be an effective strategy. In particular, hypertension
(HT) is strongly associated with HF. Meta-analyses (MA) demonstrated a
correlation, even not linear, between blood pressure (BP) decrease and HF
risk, suggesting different impacts of anti-HT strategies. In the ALLHAT
trial, the lowest rates of hospitalization and fatal HF were found for Pts
receiving diuretic or ACE inhibitor.
Methods: INDANA MA data, assessed among 1 670 Pts above 80, have
been compared to the recent, randomized, double-blind, multicentric HYVET
trial results. HYVET evaluated the benefits of treating 3845 Pts ≥ 80 years
with a sustained systolic BP≥160 mmHg using indapamide +/- perindopril
strategy (I-PS) or placebo.
Results: INDANA results showed a significant 39% reduction of HF
associated with a 6% relative excess of death from all causes in active
group. In HYVET, active treatment was associated with a 21% reduction
of all causes death (p=0,02) and a significant 64% reduction of HF (p <
0,001), with an incidence decreasing from 1,48% to 0,53% per year.
According to published figures, one HF would be prevented by treating 52
Pts during 2 years.
Conclusion: these results provide evidence that I-PS in HT Pts above 80 is
beneficial and effective for preventing HF and mortality. These results, if
applied to French population, could contribute to a significant reduction of HF
incidence among old HT patients.
Haemoglobin 
(g/L) NYHA I
NYHA II 
without 
congestive 
signs
NYHA II 
with 
congestive 
signs
NYHA III NYHA IV
n 107 448 62 295 37
Men 13.3 ± 1.6 13.4 ± 1.7 12.1 ± 1.9 12.7 ± 1.8 13.4 ± 1.6
Women 12.7 ± 1.2 12.6 ± 1.3 11.8 ± 2.5 12.1 ± 1.6 12.2 ± 2.1
Anaemia N (%) 33 (30.8) 150 (33.5) 42 (67.7)** 149 (50.5)* 15 (40.5)
* p < 0.05: NYHA III vs NYHA I,II / 
** p < 0.05 : NYHA II with congestive signs vs NYHA I,II 
without congestive signs III,IV.
